As used in this subpart, the term:

1. (1) “Body fluids” means amniotic, pericardial, peritoneal, pleural, synovial and cerebrospinal fluids, semen, vaginal secretions, and other body fluids, secretions, and excretions containing visible blood;
2. (2) “Exposure-prone procedure” means an invasive procedure in which there is a significant risk of percutaneous injury to the practitioner by virtue of digital palpation of a needle tip or other sharp instrument in a body cavity or the simultaneous presence of the practitioner’s fingers and a needle or other sharp instrument or object in a poorly visualized or highly confined anatomic site, or any other invasive procedure in which there is a significant risk of contact between the blood or body fluids of the practitioner and the blood or body fluids of the patient;
3. (3) “HbeAg seropositive” means, with respect to a practitioner, that a test of the practitioner’s blood under the criteria of the Centers for Disease Control and Prevention or approved by the Arkansas State Medical Board has confirmed the presence of the hepatitis B antigens;
4. (4) “HBV” means the hepatitis B virus;
5. (5) “HCV” means the hepatitis C virus;
6. (6) “HIV” means the human immunodeficiency virus, whether HIV-1 or HIV-2;
7. (7) “HIV seropositive” means, with respect to a practitioner, that a test under the criteria of the Centers for Disease Control and Prevention or approved by the Arkansas State Medical Board has confirmed the presence of HIV antibodies;
8. (8) “Invasive procedure” means any surgical or other diagnostic or therapeutic procedure involving manual or instrumental contact with or entry into any blood, body fluids, cavity, internal organ, subcutaneous tissue, mucous membrane, or percutaneous wound of the human body; and
9. (9) “Practitioner” means physician or physician’s trained assistant who performs or participates in an invasive procedure or functions ancillary to invasive procedures.